|
Arrhythmias, clinical electrophysiology, drugs
Citations 311-320 of 1411 total displayed.
|
Past content
(since Jan 1999):
|
- Arrhythmia/Electrophysiology
Inductionless or Limited Shock Testing Is Possible in Most Patients With Implantable Cardioverter- Defibrillators/Cardiac Resynchronization Therapy Defibrillators: Results of the Multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)
- John D. Day, Rahul N. Doshi, Peter Belott, Ulrika Birgersdotter-Green, Mahnaz Behboodikhah, Peter Ott, Kathryn A. Glatter, Serge Tobias, Howard Frumin, Byron K. Lee, John Merillat, Isaac Wiener, Samuel Wang, Harlan Grogin, Sung Chun, Rob Patrawalla, Brian Crandall, Jeffrey S. Osborn, J. Peter Weiss, Donald L. Lappe, and Stacey Neuman
Circulation 2007;115:2382-2389; published online before print as doi:10.1161/CIRCULATIONAHA.106.663112
[Abstract]
[Full text]
- Contemporary Reviews in Cardiovascular Medicine
Mechanisms of Sudden Cardiac Death in Myocardial Infarction Survivors: Insights From the Randomized Trials of Implantable Cardioverter-Defibrillators
- T. Jared Bunch, Stefan H. Hohnloser, and Bernard J. Gersh
Circulation 2007;115:2451-2457, doi:10.1161/CIRCULATIONAHA.106.683235
[Full text]
- Articles
Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene
- Arthur J. Moss, Wataru Shimizu, Arthur A.M. Wilde, Jeffrey A. Towbin, Wojciech Zareba, Jennifer L. Robinson, Ming Qi, G. Michael Vincent, Michael J. Ackerman, Elizabeth S. Kaufman, Nynke Hofman, Rahul Seth, Shiro Kamakura, Yoshihiro Miyamoto, Ilan Goldenberg, Mark L. Andrews, and Scott McNitt
Circulation published April 30, 2007, doi:10.1161/CIRCULATIONAHA.106.665406
[Abstract]
- Articles
Inductionless or Limited Shock Testing Is Possible in Most Patients With Implantable Cardioverter- Defibrillators/Cardiac Resynchronization Therapy Defibrillators. Results of the Multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)
- John D. Day, Rahul N. Doshi, Peter Belott, Ulrika Birgersdotter-Green, Mahnaz Behboodikhah, Peter Ott, Kathryn A. Glatter, Serge Tobias, Howard Frumin, Byron K. Lee, John Merillat, Isaac Wiener, Samuel Wang, Harlan Grogin, Sung Chun, Rob Patrawalla, Brian Crandall, Jeffrey S. Osborn, J. Peter Weiss, Donald L. Lappe, and Stacey Neuman
Circulation published April 30, 2007, doi:10.1161/CIRCULATIONAHA.106.663112
[Abstract]
- Images in Cardiovascular Medicine
Magnetic Resonance Imaging Guiding Pacemaker Implantation for Severe Sinus Node Dysfunction Due to Cardiac Involvement in Erdheim-Chester Disease
- Thomas Elgeti, Michael Schlegl, Aischa Nitardy, Dietmar E. Kivelitz, and Martin Stockburger
Circulation 2007;115:e412-414e, doi:10.1161/CIRCULATIONAHA.106.656439
[Full text]
- Images in Cardiovascular Medicine
Percutaneous Epicardial Mapping and Ablation of a Posteroseptal Accessory Pathway
- Ivan Ho, Andre d’Avila, Jeremy Ruskin, and Moussa Mansour
Circulation 2007;115:e418-421e, doi:10.1161/CIRCULATIONAHA.106.673855
[Full text]
- Images in Cardiovascular Medicine
Neonatal Tuberous Sclerosis and Multiple Cardiac Arrhythmias
- Yaniv Bar-Cohen, Michael J. Silka, and Mark S. Sklansky
Circulation 2007;115:e395-397e, doi:10.1161/CIRCULATIONAHA.106.659771
[Full text]
- Correspondence
Letter by Padfield et al Regarding Article, "Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After Cardiac Surgery) Study"
- Gareth J. Padfield, Nathaniel M. Hawkins, and Michael R. MacDonald
Circulation 2007;115:e403, doi:10.1161/CIRCULATIONAHA.106.667253
[Full text]
- Correspondence
Letter by Shroff and Orlandi Regarding Article, "Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After Cardiac Surgery) Study"
- Gautam R. Shroff and Quirino G. Orlandi
Circulation 2007;115:e404, doi:10.1161/CIRCULATIONAHA.106.677708
[Full text]
- Correspondence
Response to Letters Regarding Article, "Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After Cardiac Surgery) Study"
- Giuseppe Patti, Massimo Chello, Dario Candura, Andrea D’Ambrosio, Elvio Covino, Germano Di Sciascio, and Vincenzo Pasceri
Circulation 2007;115:e405, doi:10.1161/CIRCULATIONAHA.106.682484
[Full text]
|
|
